caffeic acid phenethyl ester and Arteriosclerosis

caffeic acid phenethyl ester has been researched along with Arteriosclerosis in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fujita, T; Hishikawa, K; Nakaki, T	1
Hishikawa, K; Nakaki, T	1

Reviews

1 review(s) available for caffeic acid phenethyl ester and Arteriosclerosis

Article	Year
[NF-kappa B as a therapeutic drug target]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2001, Volume: 118, Issue:3 Topics: Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Arteriosclerosis; Caffeic Acids; DNA-Binding Proteins; Drug Design; Flavonoids; Gene Transfer Techniques; Humans; I-kappa B Proteins; Immunosuppressive Agents; Inflammation; Mutation; Neoplasms; NF-kappa B; NF-KappaB Inhibitor alpha; Phenylethyl Alcohol; Steroids	2001

Article

Year

[NF-kappa B as a therapeutic drug target].

Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2001, Volume: 118, Issue:3

Topics: Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Arteriosclerosis; Caffeic Acids; DNA-Binding Proteins; Drug Design; Flavonoids; Gene Transfer Techniques; Humans; I-kappa B Proteins; Immunosuppressive Agents; Inflammation; Mutation; Neoplasms; NF-kappa B; NF-KappaB Inhibitor alpha; Phenylethyl Alcohol; Steroids

2001

Other Studies

1 other study(ies) available for caffeic acid phenethyl ester and Arteriosclerosis

Article	Year
Oral flavonoid supplementation attenuates atherosclerosis development in apolipoprotein E-deficient mice. Arteriosclerosis, thrombosis, and vascular biology, 2005, Volume: 25, Issue:2 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Aorta, Thoracic; Aortic Diseases; Apolipoproteins E; Arteriosclerosis; Caffeic Acids; Cell Adhesion Molecules; Cytokines; Depression, Chemical; Drug Evaluation, Preclinical; Extracellular Matrix Proteins; Free Radical Scavengers; Gene Expression Profiling; Gene Expression Regulation; Hyperlipoproteinemia Type II; Isoprostanes; Lipids; Male; Mice; Mice, Knockout; NF-kappa B; Oxidative Stress; Phenylethyl Alcohol; Random Allocation; Transcription Factors	2005

Article

Year

Oral flavonoid supplementation attenuates atherosclerosis development in apolipoprotein E-deficient mice.

Arteriosclerosis, thrombosis, and vascular biology, 2005, Volume: 25, Issue:2

Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Aorta, Thoracic; Aortic Diseases; Apolipoproteins E; Arteriosclerosis; Caffeic Acids; Cell Adhesion Molecules; Cytokines; Depression, Chemical; Drug Evaluation, Preclinical; Extracellular Matrix Proteins; Free Radical Scavengers; Gene Expression Profiling; Gene Expression Regulation; Hyperlipoproteinemia Type II; Isoprostanes; Lipids; Male; Mice; Mice, Knockout; NF-kappa B; Oxidative Stress; Phenylethyl Alcohol; Random Allocation; Transcription Factors

2005